The EU-funded project AIDPATH, a collaboration between twelve partners from seven countries, is aiming to increase patient’s access to CAR-T cell therapy, a promising treatment for blood cancers such ...

ANN ARBOR, Mich., June 24, 2025 /PRNewswire/ -- Akadeum Life Sciences, the world leader in advanced cell separation technology, proudly announces a groundbreaking workflow that leverages its ...

Akadeum's microbubble-based cell isolation workflow addresses critical bottlenecks in cell therapy manufacturing by providing a scalable, gentle, and fully closed GMP solution for cell separation ...

Secondary objectives include assessment of efficacy and feasibility of decentralized manufacturing of GLPG5101. The dose levels that were evaluated in Phase 1 are 50x10 6 (DL1), 110x10 6 (DL2) and ...

The most advanced Galapagos cell therapy program is GLPG5101. Though Galapagos generated encouraging early clinical data for this therapy in non-Hodgkin lymphoma, the company later selected mantle ...

Since 2020, YJ Biotechnology has been transforming regenerative medicine with its cost-efficient, internationally-certified and decentralized one-stop cell manufacturing platform supporting ...

Biotech UPDATE: Adaptimmune, after bringing cell therapy to market, questions viability and defunds 2 preclinical programs By Gabrielle Masson Mar 20, 2025 2:04pm ...

The rise of personalized medicine is promising for patients, but poses tremendous challenges around cell and gene therapy manufacturing processes. For starters, the raw materials are the patients’ own ...

Galapagos NV (NASDAQ: GLPG) Q4 2024 Earnings Conference Call February 13, 2025 8:00 AM ET Company Participants Sri Ramaswami - Senior Vice President and Global Head of Corporate Affairs & Investor ...

The firm's oncology pipeline also includes cell therapies for chronic lymphocytic leukemia, multiple myeloma, and head and neck cancer. In January, Galapagos partnered with another CDMO, Catalent, to ...

Catalent’s commercial cell therapy manufacturing facility in Princeton, New Jersey, will support manufacturing for Galapagos’ upcoming trials in New Jersey, New York, and surrounding areas. Galapagos ...